thiophene-2-carbohydrazide: structure in first source
ID Source | ID |
---|---|
PubMed CID | 73098 |
CHEMBL ID | 3091844 |
SCHEMBL ID | 355263 |
MeSH ID | M0065939 |
Synonym |
---|
BIDD:GT0451 |
nsc-120045 |
nsc120045 |
2-thiophenecarboxylic acid hydrazide |
thiophene-2-carboxylic acid hydrazide |
2-thienylcarboxylic acid hydrazide |
2-thiophenecarbohydrazonic acid |
2361-27-5 |
nsc-653 |
2-thenoylhydrazine |
nsc653 |
2-thiophenecarboxylic acid, hydrazide |
thiophene-2-carbohydrazide |
2-thiophenecarboxylic acid hydrazide, >=98% |
STK061684 |
AKOS000200290 |
2-thiophenecarboxylic hydrazide |
sogbogbtikmgfs-uhfffaoysa- |
inchi=1/c5h6n2os/c6-7-5(8)4-2-1-3-9-4/h1-3h,6h2,(h,7,8) |
T1140 |
HMS1722A21 |
2-thiophene carboxylic hydrazide |
thiophene-2-carboxylic hydrazide |
A816801 |
unii-w4j3wef93n |
nsc 653 |
einecs 219-107-0 |
w4j3wef93n , |
FT-0634215 |
PS-5271 |
SCHEMBL355263 |
CHEMBL3091844 |
2-thiophenecarboxylicacidhydrazide |
2thiophenecarboxylic hydrazide |
2-thiophene carboxylic acid hydrazide |
2-thiophencarboxylic acid hydrazide |
2-thiophenecarbohydrazide |
thenohydrazide |
W-107392 |
2-thiophenecarbohydrazide # |
2-thienyl hydrazide |
2-thenoic hydrazide |
DTXSID80178271 |
F3146-2497 |
mfcd00005435 |
BBL104270 |
thiophene-2-carboxylic hydrazone |
SY048333 |
AM9858 |
F10320 |
EN300-17658 |
CS-W018291 |
Z56974792 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID1059231 | Antitubercular activity against Mycobacterium tuberculosis | 2013 | European journal of medicinal chemistry, , Volume: 70 | Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds. |
AID1422882 | Binding affinity to recombinant Trypanosoma cruzi His/haemaglutinin-tagged BDF3 expressed in Escherichia coli BL21 at 100 uM by fluorescence spectra analysis | 2018 | ACS medicinal chemistry letters, Oct-11, Volume: 9, Issue:10 | Discovery of a Biologically Active Bromodomain Inhibitor by Target-Directed Dynamic Combinatorial Chemistry. |
AID1059234 | Lipophilicity, log P of the compound | 2013 | European journal of medicinal chemistry, , Volume: 70 | Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 11 (47.83) | 18.7374 |
1990's | 1 (4.35) | 18.2507 |
2000's | 1 (4.35) | 29.6817 |
2010's | 9 (39.13) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.58) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (4.17%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 23 (95.83%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |